Advocacy intelligence hub — real-time data for patient organizations
Phoenicia BioScience — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Deferasirox
(DEFERASIROX)Orphan drugstandardMSN LABORATORIES PRIVATE LIMITED
Mitchell S Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY
Abdullah Kutlar, MD, MD
Augusta University
📍 AUGUSTA, GA
Chen Jing, M.D.
Shanghai Children's Medical Center
📍 TORRANCE, CA
Haoquan Wu, PhD
R&D Kanglin Biotech
Juliano L Fernandes, MD
University of Campinas, Brazil
Himal Lal Thakar, MD, MD
bluebird bio, Inc.
📍 WATERBURY, CT